Obesity as a Chronic Inflammatory State Impacting Spondyloarthritis (SpA)

Understand obesity as a chronic disease and a contributor to underlying inflammatory activity that directly and negatively impacts patients with psoriatic arthritis (PsA).

References 

1. Guo Z, Yang Y, Liao Y, Shi Y, Zhang LJ. Emerging roles of adipose tissue in the pathogenesis of psoriasis and atopic dermatitis in obesity. JID Innov. 2022;2(1):100064. doi:10.1016/j.xjidi.2021.100064 

2. Aprahamian TR, Sam F. Adiponectin in cardiovascular inflammation and obesity. Int J Inflam. 2011;2011:376909. doi:10.4061/2011/376909 

3. Favaretto F, Bettini S, Busetto L, Milan G, Vettor R. Adipogenic progenitors in different organs: pathophysiological implications. Rev Endocr Metab Disord. 2022;23(1):71-85. doi:10.1007/s11154-021-09686-6  

4. Russolillo A, Iervolino S, Peluso R, et al. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford). 2013;52(1):62-67. doi:10.1093/rheumatology/kes242 

5. Hou J, He C, He W, Yang M, Luo X, Li C. Obesity and bone health: a complex link. Front Cell Dev Biol. 2020;8:600181. doi:10.3389/fcell.2020.600181 

6. Klingberg E, Bilberg A, Björkman S, et al. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther. 2019;21(1):17. doi:10.1186/s13075-019-1810-5 

7. Slouma M, Kharrat L, Tezegdenti A, Dhahri R, Ghazouani E, Gharsallah I. Pro-inflammatory cytokines in spondyloarthritis: a case-control study. Expert Rev Clin Immunol. 2024;20(6):655-663. doi:10.1080/1744666X.2024.2304080 

8. Kumthekar A, Ogdie A. Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther. 2020;7(3):447-456. doi:10.1007/s40744-020-00215-6 

9. Love TJ, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71(8):1273-1277. doi:10.1136/annrheumdis-2012-201299 

10. Porta S, Otero-Losada M, Kölliker Frers RA, Cosentino V, Kerzberg E, Capani F. Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis. Front Immunol. 2021;11:590749. doi:10.3389/fimmu.2020.590749